|
|
|
PHARMACOKINETIC DESCRIPTION OF PLASMA LEVELS OF DRUGS - EXTRAVASCULAR DOSING
(a) Introduction:
Eg. oral, IM, SC, dosing.
Drug at absorption site ka Drug in body k Metabolism and excretion ![]()
Absorption generally first order process,
ie. rate = ka . Aa
t½
= 0.693 / ka
Occasionally zero-order.
(b) Plasma concentrations:
Distinct phases:-
(i) Absorption > elimination.
(ii) (peak) Absorptionelimination.
(iii) Absorption < elimination.
(iv) Absorption0; elimination only.
Lag-time.
(c) Mathematical description of plasma concentration:
C ![]()
= F . D . ka (e - e
)
________________
(ka - k) Vd . = A (e - e
)
. . Where A
= F . D . ka ________________
(ka - k) Vd . = Ae - Ae
)
Normally, ka >> k
(d) Determination of ka by method of residuals (R&T Page 293):
Post-absorptive phase
C
= A e
determine k
Extrapolate back to intercept (A)
A
= F . D . ka
________________
(ka - k) Vd
. If ka >> k . then A ![]()
F . D . ka
________________
ka . Vd
. = F . D
________________
Vd
Now; C
= Ae
- Ae
a e
= a e
- C
a second line (A e
) can be constructed by subtracting C
from Ae
Slope = -ka / 2.303
Normally, ka >> k
NB If k >> ka (eg. slow-release formulation) then the terminal portion of curve describes absorption, rather than elimination (ie. absorption rate - limited elimination)
"flip - flop" model.
(e) Distinguishing whether ka or k is rate - limiting:
Alter the absorption kinetics.
(f) Determination of extent of absorption (F):
(i) Plasma levels:
Recall for IV dosing: -
Dose = Cl x AUC
with extravascular dosing:-
F . D = Cl x AUC
Ie. F = (Cl x AUC) / D
(ii) Urine data:
F =
Xu
oral
________
Xu
IV
MULTIPLE DOSING AND DOSAGE REGIMEN DESIGN
Aim:
To achieve and maintain a desired plasma level of drug.


(a) Intravenous infusion:
(See previous notes)
- C
= Rinf / Cl
- Time to reach steady state (approx. 4 or 5 x t½).
(b) Repeated IV doses:
= dosage interval
n = number of doses
D = dose
t = time after dose number n
Plasma concentration at any time (t) after dose (n):
C =
D (1 - e
)
. e ![]()
________________
Vd (1 - e
)
Maximum plasma concentration after any dose:
Cmax =
D (1 - e
)
(t = 0) ________________
Vd (1 - e
)
Minimum plasma concentration after any dose:
Cmin =
D (1 - e
)
. e ![]()
(t = t) ________________
Vd (1 - e
)
At steady - state: (n ® ¥ ; e-nkt ® 0)
\ C
= D
. e ![]()
________________
Vd (1 - e
)
. C ![]()
= D (t=0) ________________
Vd (1 - e )
. C ![]()
= D . e ![]()
(t=t) ________________
Vd (1 - e )
at C
:
rate in = rate out
rate in = rate out . \ D = C . Cl
________
![]()
. C ![]()
= D _________
Cl . ![]()
Accumulation ratio (Rac):
Rac
= Average amount of drug in body at steady - state
= 1 ________________________________________________
________
dose
k ![]()
Loading Dose:
MD = LD (1 - e-kt)
NB If
![]()
t½, then MD
½ x LD
Fluctuation in plasma levels at steady-state:
% Fluctuation = 100 x C - C
________________
C . = 100 x C - C
.e
____________________
C . = 100 x C (1 - e
)
________________
C . = 100(1 - e )
\ fluctuation is governed solely by t½ and
(c) Repeated Oral Doses:
C
= ka . F . D (1 - e
![]()
. e ![]()
1 - e )
___________________
______________
Vd (ka - k) (1 - e
1 - e . e
)
At steady-state:
C ![]()
= F . D _________
Cl . ![]()
Assuming ka >> k:
C ![]()
= F . l _________
Vd ( 1 -e )
Assuming ka » k:
C ![]()
= F . D ________________
Vd ( 1 -e ) . e
![]()
Loading Dose:
MD = LD (1 - e
)
Importance of Half-life in Dosage Regimen Design:
1. Governs time to reach steady-state:
2. Governs dosage interval selection:
To minimise fluctuation in plasma levels, the dosage interval is generally
t½.
Drug Approx t½ (hrs) Approx (hrs)
Digoxin 35 24 Warfarin 30 24 Pethidine 3.5 4 Procainamide 3.5 4 Tetracycline 8 6 Doxycycline 20 24 Importance of therapeutic index:
Eg. Penicillin G
t½ ~ 0.5 hrs, but
~ 4-6 hrs.
Problem
A patient (56 years old; 70kg; renal function normal) is to start oral Digoxin therapy. Please advise Doctor in relation to:-
(a) Appropriate daily dose?
(b) Time to see full effects? (Assume t½ = 40 hrs)
(c) Loading dose, if needed?
![]() ![]() ![]() |